Viral Infections are illnesses or other pathological states caused by viruses, which are infectious agents consisting principally of genetic material enclosed within a protein coat and, in many viruses, surrounded by a lipid envelope. Unlike bacteria, fungi, and parasites, viruses lack the cellular machinery required for independent replication and must enter susceptible host cells to reproduce. Their genomes may consist of DNA or RNA and may be single-stranded or double-stranded, depending on the virus.
Viral infections range from brief, self-limited illnesses to persistent, latent, recurrent, or progressive diseases. Examples include influenza, measles, chickenpox, COVID-19, hepatitis B, hepatitis C, HIV infection, and herpesvirus infections. The clinical effect depends on the virus, the tissues it infects, the host immune response, and whether infection remains localised or becomes systemic.
Viral replication begins when a virus attaches to a compatible host-cell receptor and enters the cell, although the precise sequence differs substantially among viruses. The viral genome then directs production of viral proteins and replication of viral genetic material using host-cell machinery, viral enzymes, or combinations of both. Newly assembled virions can leave cells through mechanisms such as cell lysis, budding, or exocytosis.
Viral tropism describes the preference of a virus for particular cell types or tissues and is determined by factors including receptor availability, intracellular conditions, host immunity, and viral replication requirements. Some viruses establish latency, in which their genetic material persists with limited or no active production of infectious particles, allowing later reactivation. Others cause persistent infection through continuous replication or mechanisms that evade immune clearance.
Transmission varies according to the specific virus and can occur through respiratory particles, direct contact, contaminated surfaces, blood, sexual contact, faecal-oral exposure, contaminated food or water, congenital transmission, or arthropod vectors. Respiratory viruses can spread when infected people release virus-containing particles while breathing, speaking, coughing, or sneezing, whereas bloodborne viruses require different exposure routes. The infectious period is also virus-specific and can begin before symptoms appear, meaning that visible illness is not always a reliable indicator of contagiousness.
Environmental persistence differs substantially between viruses because envelope structure, temperature, humidity, ultraviolet radiation, and surface conditions can affect survival. Understanding the transmission route determines which prevention measures are relevant, such as vaccination, ventilation, hand hygiene, safer sex, blood screening, isolation, vector control, or food and water precautions.
Symptoms of Viral Infections reflect both direct effects of viral replication and the host's immune response. Common manifestations include fever, fatigue, cough, sore throat, gastrointestinal symptoms, rash, muscle aches, and headache, but some infections are asymptomatic or produce highly organ-specific disease. Severe viral disease can involve pneumonia, encephalitis, hepatitis, myocarditis, neurological complications, haemorrhage, or multi-organ dysfunction depending on the pathogen.
Diagnosis can involve nucleic-acid amplification tests such as PCR, antigen detection, antibody testing, viral culture in selected circumstances, or clinical assessment supported by epidemiological information. PCR detects viral genetic material and can be highly sensitive, whereas antibody tests generally provide information about immune response and may not establish active infection by themselves. Correct interpretation depends on the timing of specimen collection, disease stage, prior infection, vaccination, and test characteristics.
The immune system uses innate and adaptive mechanisms to control Viral Infections. Innate responses include physical barriers, interferon signalling, inflammatory pathways, natural killer cells, and other early defences, while adaptive immunity involves virus-specific T cells and antibodies. Antibodies can neutralise viruses or interfere with their attachment and entry, while cytotoxic T cells can recognise and destroy infected cells. Some viruses have evolved mechanisms that interfere with antigen presentation, interferon responses, apoptosis, or other immune processes.
Immunity may be sterilising, reducing the likelihood of infection entirely, or protective mainly against severe disease. Duration and effectiveness of immunity vary substantially among viruses, and viral antigenic change can alter susceptibility. These mechanisms explain why vaccination can provide strong protection against some viruses while requiring periodic updating for others.
Treatment depends on the virus and the severity of disease. Many common viral infections are managed primarily with supportive care, such as appropriate hydration, rest, symptom management, and monitoring for complications. Antiviral medicines exist for selected infections and work through mechanisms such as inhibiting viral polymerases, proteases, entry processes, or other stages of replication. Examples include antiretroviral combinations for HIV and specific antiviral therapies for some influenza, herpesvirus, hepatitis, and other infections.
Antiviral resistance can arise when genetic mutations reduce drug susceptibility, particularly when replication is extensive or treatment is incomplete or poorly matched to the virus. Antibiotics do not treat Viral Infections because antibiotics target bacterial structures or processes that viruses do not possess. Using antibiotics for uncomplicated viral illness therefore provides no antiviral benefit and can contribute to antimicrobial resistance and adverse effects.
Vaccination is one of the most important tools for preventing specific Viral Infections. Vaccines expose the immune system to an antigen or genetic instruction associated with a pathogen without requiring the disease-causing infection itself, allowing immune memory to develop. Vaccine technologies include live attenuated, inactivated, protein-based, viral-vector, and nucleic-acid platforms, among others. Effectiveness depends on the vaccine, pathogen, population, schedule, circulating variants, and outcome being measured.
Other prevention measures include respiratory hygiene, ventilation, hand hygiene, safe injection practices, blood screening, sexual-health measures, maternal interventions, and vector control where applicable. Public-health measures can be particularly important during outbreaks because viruses can spread rapidly through susceptible populations. Prevention strategies must be matched to the transmission biology of the particular virus rather than applying one generic approach to all viral diseases.
Viral Infections differ fundamentally from bacterial, fungal, and parasitic infections because viruses depend on host cells for replication. The word "virus" derives from Latin for poison or slimy liquid, reflecting historical descriptions made before the infectious nature of viruses was understood. Modern virology developed substantially after the recognition that some infectious agents could pass through filters that retained bacteria, followed by advances in electron microscopy, molecular biology, genome sequencing, and cell culture.
Viruses can infect humans, animals, plants, fungi, and even bacteria, and their evolutionary relationships are diverse. A common misconception is that every viral infection produces obvious symptoms or requires medication; many infections are asymptomatic or self-limited, while selected infections require highly specific antiviral treatment. Another misconception is that all viral infections are harmless because some resolve spontaneously: certain viruses can cause severe acute disease, persistent infection, cancer, congenital abnormalities, or long-term organ damage.
